Bio-Techne (TECH) Current Leases (2019 - 2026)
Bio-Techne's quarterly Current Leases came in at $14.2 million in Q1 2026, up 0.94% year-on-year from $14.0 million in Q1 2025, and up 3.44% quarter-over-quarter from $13.7 million in Q4 2025.
Bio-Techne has reported Current Leases for 8 years, with the latest figure at $14.2 million in Q1 2026.
- For the quarter ending Q1 2026, Current Leases rose 0.94% year-over-year to $14.2 million; the trailing twelve-month figure through Mar 2026 stood at $14.2 million (up 0.94% YoY), and the FY2025 full-year result was $14.1 million, up 9.12% from the prior year.
- Current Leases for Q1 2026 stood at $14.2 million, up from $13.7 million in the prior quarter.
- The five-year high for Current Leases was $14.2 million in Q1 2026, with the low at $10.7 million in Q1 2023.
- Average Current Leases over 5 years is $12.7 million, with a median of $12.9 million recorded in 2024.
- Year-over-year, Current Leases decreased 9.62% in 2023 and grew 21.03% in 2024.
- Tracing TECH's Current Leases over 5 years: stood at $11.0 million in 2022, then climbed by 15.46% to $12.7 million in 2023, then advanced by 6.62% to $13.5 million in 2024, then increased by 1.47% to $13.7 million in 2025, then climbed by 3.44% to $14.2 million in 2026.
- The last three Current Leases figures came in at $14.2 million (Q1 2026), $13.7 million (Q4 2025), and $13.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 83,991.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 720.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 45.66 Mn |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn | 14.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.18 Mn |
| Dec 31, 2025 | 13.71 Mn |
| Sep 30, 2025 | 13.77 Mn |
| Jun 30, 2025 | 14.10 Mn |
| Mar 31, 2025 | 14.05 Mn |
| Dec 31, 2024 | 13.51 Mn |
| Sep 30, 2024 | 13.49 Mn |
| Jun 30, 2024 | 12.92 Mn |
| Mar 31, 2024 | 12.98 Mn |
| Dec 31, 2023 | 12.67 Mn |
| Sep 30, 2023 | 12.20 Mn |
| Jun 30, 2023 | 11.20 Mn |
| Mar 31, 2023 | 10.72 Mn |
| Dec 31, 2022 | 10.98 Mn |
| Sep 30, 2022 | 12.12 Mn |
| Jun 30, 2022 | 11.93 Mn |
| Mar 31, 2022 | 11.86 Mn |
| Dec 31, 2021 | 11.81 Mn |
| Sep 30, 2021 | 12.00 Mn |
| Jun 30, 2021 | 11.60 Mn |
| Mar 31, 2021 | 10.41 Mn |
| Dec 31, 2020 | 9.91 Mn |
| Sep 30, 2020 | 9.70 Mn |
| Jun 30, 2020 | 9.54 Mn |
| Mar 31, 2020 | 9.54 Mn |
| Dec 31, 2019 | 9.40 Mn |
| Sep 30, 2019 | 9.26 Mn |